{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T16:29:39Z","timestamp":1709137779962},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00059-021-05056-9","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T12:02:42Z","timestamp":1628596962000},"page":"437-444","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Aktuelle Technologien zur interventionellen Therapie der Trikuspidalklappeninsuffizienz"],"prefix":"10.1007","volume":"46","author":[{"given":"Sebastian","family":"Rosch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Lurz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"issue":"11","key":"5056_CR1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/eurheartj\/ehs465","volume":"34","author":"S Neuhold","year":"2013","unstructured":"Neuhold\u00a0S, Huelsmann\u00a0M, Pernicka\u00a0E et al (2013) Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a\u00a0long-term observational study. Eur Heart\u00a0J 34(11):844\u2013852. https:\/\/doi.org\/10.1093\/eurheartj\/ehs465","journal-title":"Eur Heart J"},{"issue":"6","key":"5056_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jacc.2019.04.028","volume":"74","author":"AL Axtell","year":"2019","unstructured":"Axtell\u00a0AL, Bhambhani\u00a0V, Moonsamy\u00a0P et\u00a0al (2019) Surgery does not improve survival in patients with isolated severe tricuspid regurgitation. J\u00a0Am Coll Cardiol 74(6):715\u2013725. https:\/\/doi.org\/10.1016\/j.jacc.2019.04.028","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"5056_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jcmg.2018.06.014","volume":"12","author":"Y Topilsky","year":"2019","unstructured":"Topilsky\u00a0Y, Maltais\u00a0S, Medina Inojosa\u00a0J et\u00a0al (2019) Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging 12(3):433\u2013442. https:\/\/doi.org\/10.1016\/j.jcmg.2018.06.014","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"5056_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1055\/s-0040-1710569","volume":"68","author":"A Beckmann","year":"2020","unstructured":"Beckmann\u00a0A, Meyer\u00a0R, Lewandowski\u00a0J et\u00a0al (2020) German heart surgery report 2019: the annual updated registry of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 68(4):263\u2013276. https:\/\/doi.org\/10.1055\/s-0040-1710569","journal-title":"Thorac Cardiovasc Surg"},{"issue":"6","key":"5056_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.pcad.2019.10.009","volume":"62","author":"M Enriquez-Sarano","year":"2019","unstructured":"Enriquez-Sarano\u00a0M, Messika-Zeitoun\u00a0D, Topilsky\u00a0Y et al (2019) Tricuspid regurgitation is a\u00a0public health crisis. Prog Cardiovasc Dis 62(6):447\u2013451. https:\/\/doi.org\/10.1016\/j.pcad.2019.10.009","journal-title":"Prog Cardiovasc Dis"},{"issue":"12","key":"5056_CR6","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.jacc.2015.01.025","volume":"65","author":"J Schofer","year":"2015","unstructured":"Schofer\u00a0J, Bijuklic\u00a0K, Tiburtius\u00a0C et al (2015) First-in-human transcatheter tricuspid valve repair in a\u00a0patient with severely regurgitant tricuspid valve. J\u00a0Am Coll Cardiol 65(12):1190\u20131195. https:\/\/doi.org\/10.1016\/j.jacc.2015.01.025","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"5056_CR7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/eurheartj\/ehv710","volume":"37","author":"C Hammerstingl","year":"2016","unstructured":"Hammerstingl\u00a0C, Schueler\u00a0R, Malasa\u00a0M et\u00a0al (2016) Transcatheter treatment of severe tricuspid regurgitation with the MitraClip system. Eur Heart\u00a0J 37(10):849\u2013853. https:\/\/doi.org\/10.1093\/eurheartj\/ehv710","journal-title":"Eur Heart J"},{"issue":"24","key":"5056_CR8","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1016\/j.jacc.2019.09.028","volume":"74","author":"M Taramasso","year":"2019","unstructured":"Taramasso\u00a0M, Benfari\u00a0G, van der Bijl\u00a0P et\u00a0al (2019) Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation. J\u00a0Am Coll Cardiol 74(24):2998\u20133008. https:\/\/doi.org\/10.1016\/j.jacc.2019.09.028","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"5056_CR9","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1002\/ejhf.1975","volume":"22","author":"KP Kresoja","year":"2020","unstructured":"Kresoja\u00a0KP, Lauten\u00a0A, Orban\u00a0M et\u00a0al (2020) Transcatheter tricuspid valve repair in the setting of heart failure with preserved or reduced left ventricular ejection fraction. Eur J Heart Fail 22(10):1817\u20131825. https:\/\/doi.org\/10.1002\/ejhf.1975","journal-title":"Eur J Heart Fail"},{"issue":"10213","key":"5056_CR10","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/S0140-6736(19)32600-5","volume":"394","author":"G Nickenig","year":"2019","unstructured":"Nickenig\u00a0G, Weber\u00a0M, Lurz\u00a0P et al (2019) Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6\u2011month outcomes of the TRILUMINATE single-arm study. Lancet 394(10213):2002\u20132011. https:\/\/doi.org\/10.1016\/S0140-6736(19)32600-5","journal-title":"Lancet"},{"issue":"29","key":"5056_CR11","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1093\/eurheartj\/ehaa138","volume":"41","author":"P Lurz","year":"2020","unstructured":"Lurz\u00a0P, Orban\u00a0M, Besler\u00a0C et\u00a0al (2020) Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair. Eur Heart\u00a0J 41(29):2785\u20132795. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa138","journal-title":"Eur Heart J"},{"key":"5056_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2021.03.052","author":"M Kitamura","year":"2021","unstructured":"Kitamura\u00a0M, Kresoja\u00a0KP, Besler\u00a0C et al (2021) Impact of tricuspid valve morphology on clinical outcomes after transcatheter edge-to-edge repair. JACC Cardiovasc Interv. https:\/\/doi.org\/10.1016\/j.jcin.2021.03.052","journal-title":"JACC Cardiovasc Interv"},{"key":"5056_CR13","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-20-01295","author":"NP Fam","year":"2021","unstructured":"Fam\u00a0NP, Ali\u00a0FM, Hassanin\u00a0M, Ong\u00a0G (2021) Transcatheter tricuspid valve repair with the modified Triclip\/Mitraclip G4 system. EuroIntervention. https:\/\/doi.org\/10.4244\/EIJ-D-20-01295","journal-title":"EuroIntervention"},{"issue":"12","key":"5056_CR14","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1093\/ehjci\/jex139","volume":"18","author":"RT Hahn","year":"2017","unstructured":"Hahn\u00a0RT, Zamorano\u00a0JL (2017) The need for a\u00a0new tricuspid regurgitation grading scheme. Eur Heart J Cardiovasc Imaging 18(12):1342\u20131343. https:\/\/doi.org\/10.1093\/ehjci\/jex139","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"3","key":"5056_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jacc.2020.11.038","volume":"77","author":"P Lurz","year":"2021","unstructured":"Lurz\u00a0P, von Bardeleben\u00a0SR, Weber\u00a0M et al (2021) Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation. J\u00a0Am Coll Cardiol 77(3):229\u2013239. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.038","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"5056_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jacc.2020.11.047","volume":"77","author":"S Kodali","year":"2021","unstructured":"Kodali\u00a0S, Hahn\u00a0RT, Eleid\u00a0MF et\u00a0al (2021) Feasibility study of the transcatheter valve repair system for severe tricuspid regurgitation. J\u00a0Am Coll Cardiol 77(4):345\u2013356. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.047","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"5056_CR17","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/ccd.29583","volume":"97","author":"M Kitamura","year":"2021","unstructured":"Kitamura\u00a0M, Fam\u00a0NP, Braun\u00a0D et al (2021) 12-Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation. Catheter Cardiovasc Interv 97(6):1281\u20131289. https:\/\/doi.org\/10.1002\/ccd.29583","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"5056_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1161\/CIRCIMAGING.111.967919","volume":"5","author":"Y Topilsky","year":"2012","unstructured":"Topilsky\u00a0Y, Khanna\u00a0A, Le Tourneau\u00a0T et\u00a0al (2012) Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension. Circ Cardiovasc Imaging 5(3):314\u2013323. https:\/\/doi.org\/10.1161\/CIRCIMAGING.111.967919","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"5056_CR19","first-page":"368","volume":"21","author":"S Messer","year":"2012","unstructured":"Messer\u00a0S, Moseley\u00a0E, Marinescu\u00a0M et\u00a0al (2012) Histologic analysis of the right atrioventricular junction in the adult human heart. J\u00a0Heart Valve Dis 21(3):368\u2013373","journal-title":"J Heart Valve Dis"},{"issue":"15","key":"5056_CR20","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.jacc.2019.01.062","volume":"73","author":"G Nickenig","year":"2019","unstructured":"Nickenig\u00a0G, Weber\u00a0M, Schueler\u00a0R et al (2019) 6\u2011Month outcomes of tricuspid valve reconstruction for patients with severe tricuspid regurgitation. J\u00a0Am Coll Cardiol 73(15):1905\u20131915. https:\/\/doi.org\/10.1016\/j.jacc.2019.01.062","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"5056_CR21","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/eurheartj\/ehv603","volume":"37","author":"F Maisano","year":"2016","unstructured":"Maisano\u00a0F, Taramasso\u00a0M, Nickenig\u00a0G et al (2016) Cardioband, a\u00a0transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. Eur Heart\u00a0J 37(10):817\u2013825. https:\/\/doi.org\/10.1093\/eurheartj\/ehv603","journal-title":"Eur Heart J"},{"issue":"16","key":"5056_CR22","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1093\/eurheartj\/ehw660","volume":"38","author":"S Kuwata","year":"2017","unstructured":"Kuwata\u00a0S, Taramasso\u00a0M, Nietlispach\u00a0F, Maisano\u00a0F (2017) Transcatheter tricuspid valve repair toward a\u00a0surgical standard: first-in-man report of direct annuloplasty with a\u00a0cardioband device to treat severe functional tricuspid regurgitation. Eur Heart\u00a0J 38(16):1261. https:\/\/doi.org\/10.1093\/eurheartj\/ehw660","journal-title":"Eur Heart J"},{"issue":"39","key":"5056_CR23","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1093\/eurheartj\/ehy536","volume":"39","author":"RS von Bardeleben","year":"2018","unstructured":"von Bardeleben\u00a0RS, Ruf\u00a0T, Schulz\u00a0E et al (2018) First percutaneous COMBO therapy of tricuspid regurgitation using direct annuloplasty and staged edge-to-edge repair in a\u00a0surgical-like Clover technique. Eur Heart\u00a0J 39(39):3621\u20133622. https:\/\/doi.org\/10.1093\/eurheartj\/ehy536","journal-title":"Eur Heart J"},{"issue":"1","key":"5056_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/ehjci\/jey153","volume":"20","author":"A Sugiura","year":"2019","unstructured":"Sugiura\u00a0A, Weber\u00a0M, Sinning\u00a0JM et\u00a0al (2019) Staged transcatheter valve repair via MitraClip XTR after cardioband for tricuspid regurgitation. Eur Heart J Cardiovasc Imaging 20(1):118. https:\/\/doi.org\/10.1093\/ehjci\/jey153","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"3","key":"5056_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.iccl.2019.02.001","volume":"8","author":"JH Rogers","year":"2019","unstructured":"Rogers\u00a0JH, Boyd\u00a0WD, Smith\u00a0TW, Bolling\u00a0SF (2019) Transcatheter Mitral valve direct annuloplasty with the Millipede IRIS ring. Interv Cardiol Clin 8(3):261\u2013267. https:\/\/doi.org\/10.1016\/j.iccl.2019.02.001","journal-title":"Interv Cardiol Clin"},{"issue":"6","key":"5056_CR26","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.pcad.2019.11.008","volume":"62","author":"JH Rogers","year":"2019","unstructured":"Rogers\u00a0JH, Boyd\u00a0WD, Bolling\u00a0SF (2019) Tricuspid annuloplasty with the Millipede ring. Prog Cardiovasc Dis 62(6):486\u2013487. https:\/\/doi.org\/10.1016\/j.pcad.2019.11.008","journal-title":"Prog Cardiovasc Dis"},{"issue":"3","key":"5056_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jcin.2014.10.013","volume":"8","author":"T Rogers","year":"2015","unstructured":"Rogers\u00a0T, Ratnayaka\u00a0K, Sonmez\u00a0M et\u00a0al (2015) Transatrial intrapericardial tricuspid annuloplasty. JACC Cardiovasc Interv 8(3):483\u2013491. https:\/\/doi.org\/10.1016\/j.jcin.2014.10.013","journal-title":"JACC Cardiovasc Interv"},{"issue":"Y","key":"5056_CR28","doi-asserted-by":"publisher","first-page":"Y119","DOI":"10.4244\/EIJV12SYA33","volume":"12","author":"J Schofer","year":"2016","unstructured":"Schofer\u00a0J (2016) Transcatheter interventions for tricuspid regurgitation: Trialign and Mitralign. EuroIntervention 12(Y):Y119\u2013Y120. https:\/\/doi.org\/10.4244\/EIJV12SYA33","journal-title":"EuroIntervention"},{"issue":"1","key":"5056_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.15420\/icr.2017:21:1","volume":"13","author":"C Besler","year":"2018","unstructured":"Besler\u00a0C, Meduri\u00a0CU, Lurz\u00a0P (2018) Transcatheter treatment of functional tricuspid regurgitation using the Trialign device. Interv Cardiol 13(1):8\u201313. https:\/\/doi.org\/10.15420\/icr.2017:21:1","journal-title":"Interv Cardiol"},{"issue":"5","key":"5056_CR30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jcin.2020.11.045","volume":"14","author":"NP Fam","year":"2021","unstructured":"Fam\u00a0NP, von Bardeleben\u00a0RS, Hensey\u00a0M et al (2021) Transfemoral transcatheter tricuspid valve replacement with the EVOQUE system: a multicenter, observational, first-in-human experience. JACC Cardiovasc Interv 14(5):501\u2013511. https:\/\/doi.org\/10.1016\/j.jcin.2020.11.045","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"5056_CR31","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jcmg.2018.08.034","volume":"12","author":"RT Hahn","year":"2019","unstructured":"Hahn\u00a0RT, George\u00a0I, Kodali\u00a0SK et al (2019) Early single-site experience with transcatheter tricuspid valve replacement. JACC Cardiovasc Imaging 12(3):416\u2013429. https:\/\/doi.org\/10.1016\/j.jcmg.2018.08.034","journal-title":"JACC Cardiovasc Imaging"},{"issue":"18","key":"5056_CR32","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.jacc.2013.01.070","volume":"61","author":"M Laule","year":"2013","unstructured":"Laule\u00a0M, Stangl\u00a0V, Sanad\u00a0W et al (2013) Percutaneous transfemoral management of severe secondary tricuspid regurgitation with Edwards Sapien XT bioprosthesis: first-in-man experience. J\u00a0Am Coll Cardiol 61(18):1929\u20131931. https:\/\/doi.org\/10.1016\/j.jacc.2013.01.070","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"5056_CR33","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.4244\/EIJ-D-19-00901","volume":"15","author":"H Dreger","year":"2020","unstructured":"Dreger\u00a0H, Mattig\u00a0I, Hewing\u00a0B et\u00a0al (2020) Treatment of severe TRIcuspid regurgitation in patients with advanced heart failure with CAval vein implantation of the edwards Sapien XT VALve (TRICAVAL): a\u00a0randomised controlled trial. EuroIntervention 15(17):1506\u20131513. https:\/\/doi.org\/10.4244\/EIJ-D-19-00901","journal-title":"EuroIntervention"},{"issue":"Y","key":"5056_CR34","doi-asserted-by":"publisher","first-page":"Y116","DOI":"10.4244\/EIJV12SYA32","volume":"12","author":"HR Figulla","year":"2016","unstructured":"Figulla\u00a0HR, Kiss\u00a0K, Lauten\u00a0A (2016) Transcatheter interventions for tricuspid regurgitation\u2014heterotopic technology: TricValve. EuroIntervention 12(Y):Y116\u2013Y118. https:\/\/doi.org\/10.4244\/EIJV12SYA32","journal-title":"EuroIntervention"},{"issue":"2","key":"5056_CR35","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1161\/CIRCINTERVENTIONS.113.001033","volume":"7","author":"A Lauten","year":"2014","unstructured":"Lauten\u00a0A, Doenst\u00a0T, Hamadanchi\u00a0A et al (2014) Percutaneous bicaval valve implantation for transcatheter treatment of tricuspid regurgitation: clinical observations and 12-month follow-up. Circ Cardiovasc Interv 7(2):268\u2013272. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.113.001033","journal-title":"Circ Cardiovasc Interv"},{"issue":"7","key":"5056_CR36","doi-asserted-by":"publisher","first-page":"758","DOI":"10.4244\/EIJ-D-18-00440","volume":"14","author":"S Toggweiler","year":"2018","unstructured":"Toggweiler\u00a0S, De Boeck\u00a0B, Brinkert\u00a0M et al (2018) First-in-man implantation of the Tricento transcatheter heart valve for the treatment of severe tricuspid regurgitation. EuroIntervention 14(7):758\u2013761. https:\/\/doi.org\/10.4244\/EIJ-D-18-00440","journal-title":"EuroIntervention"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-021-05056-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-021-05056-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-021-05056-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T13:08:07Z","timestamp":1633007287000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-021-05056-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["5056"],"URL":"https:\/\/doi.org\/10.1007\/s00059-021-05056-9","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,10]]},"assertion":[{"value":"8 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.\u00a0Lurz: consultant of Edwards Lifesciences, Medtronic, Abbott Vascular, ReCor and research relationship to Edwards Lifesciences, ReCor. S.\u00a0Rosch gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}